It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Until recently, Shigella and enteroinvasive Escherichia coli were thought to be primate-restricted pathogens. The base of their pathogenicity is the type 3 secretion system (T3SS) encoded by the pINV virulence plasmid, which facilitates host cell invasion and subsequent proliferation. A large family of T3SS effectors, E3 ubiquitin-ligases encoded by the ipaH genes, have a key role in the Shigella pathogenicity through the modulation of cellular ubiquitination that degrades host proteins. However, recent genomic studies identified ipaH genes in the genomes of Escherichia marmotae, a potential marmot pathogen, and an E. coli extracted from fecal samples of bovine calves, suggesting that non-human hosts may also be infected by these strains, potentially pathogenic to humans. We performed a comparative genomic study of the functional repertoires in the ipaH gene family in Shigella and enteroinvasive Escherichia from human and predicted non-human hosts. We found that fewer than half of Shigella genomes had a complete set of ipaH genes, with frequent gene losses and duplications that were not consistent with the species tree and nomenclature. Non-human host IpaH proteins had a diverse set of substrate-binding domains and, in contrast to the Shigella proteins, two variants of the NEL C-terminal domain. Inconsistencies between strains phylogeny and composition of effectors indicate horizontal gene transfer between E. coli adapted to different hosts. These results provide a framework for understanding of ipaH-mediated host-pathogens interactions and suggest a need for a genomic study of fecal samples from diseased animals.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 A.A. Kharkevich Institute for Information Transmission Problems, Moscow, Russia (GRID:grid.435025.5) (ISNI:0000 0004 0619 6198)
2 A.A. Kharkevich Institute for Information Transmission Problems, Moscow, Russia (GRID:grid.435025.5) (ISNI:0000 0004 0619 6198); Skolkovo Institute of Science and Technology, Moscow, Russia (GRID:grid.454320.4) (ISNI:0000 0004 0555 3608); Russian Academy of Sciences, FRC PSCBR RAS, Moscow Region, Institute of Cell Biophysics, Pushchino, Russia (GRID:grid.470117.4)
3 A.A. Kharkevich Institute for Information Transmission Problems, Moscow, Russia (GRID:grid.435025.5) (ISNI:0000 0004 0619 6198); Skolkovo Institute of Science and Technology, Moscow, Russia (GRID:grid.454320.4) (ISNI:0000 0004 0555 3608)
4 Institute of Science and Technology Austria, Klosterneuburg, Austria (GRID:grid.33565.36) (ISNI:0000000404312247)